White Paper

Blinding Clinical Supplies Utilizing Over-Encapsulation

Source: CapsugelĀ® | Lonza Pharma & Biotech

During the preparation of clinical studies, the method for visually blinding the dosage form is a decision that needs to be made early on in the process. While there are many blinding options available today, i.e., deprinting, mill & fill, manufacture of generic drug, and over-encapsulation to name a few, the over-encapsulation method still seems to be the most popular method. Submitted by Capsugel

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: